Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)
Exploration of A Holistic Management Procedure for Liver Cancer Surveillance in Improving Liver Cancer's Early Diagnosis Efficacy in Chinese Population: Single-Center, Prospective, Observational Real-world Study in EASTERN China
Ruijin Hospital
20,000 participants
Mar 1, 2023
OBSERVATIONAL
Conditions
Summary
The goal of this study is to evaluate whether the standardized liver cancer risk stratification management can effectively improve the early diagnosis rate of liver cancer in the targeted risk population in China.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Follow up every 3 months for liver cancer surveillance, including but not limited to serum AFP test and ultrasound exam
Follow up every 6 months for liver cancer surveillance, including but not limited to serum AFP test and ultrasound exam
Follow up annually for liver cancer surveillance, including but not limited to serum AFP test and ultrasound exam
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05870969